| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,225 |
2,127 |
$113K |
| 80053 |
Comprehensive metabolic panel |
18,349 |
15,888 |
$94K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,859 |
18,277 |
$66K |
| 84443 |
Thyroid stimulating hormone (TSH) |
7,742 |
7,285 |
$63K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
549 |
525 |
$38K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,909 |
1,744 |
$34K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
783 |
720 |
$28K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,189 |
3,768 |
$22K |
| 80061 |
Lipid panel |
5,010 |
4,755 |
$19K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
707 |
634 |
$17K |
| 87486 |
|
728 |
669 |
$17K |
| 87581 |
|
728 |
669 |
$17K |
| 87430 |
|
2,075 |
1,993 |
$16K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,551 |
2,560 |
$15K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
260 |
250 |
$14K |
| 83735 |
|
3,967 |
2,960 |
$13K |
| 84484 |
|
3,209 |
2,648 |
$13K |
| 87081 |
|
4,547 |
4,372 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
867 |
837 |
$13K |
| 86703 |
|
1,274 |
1,238 |
$12K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,558 |
3,393 |
$11K |
| 84439 |
|
2,514 |
2,409 |
$11K |
| 83690 |
|
3,029 |
2,679 |
$10K |
| 87186 |
|
1,747 |
1,616 |
$10K |
| 82607 |
|
1,605 |
1,529 |
$10K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
420 |
340 |
$9K |
| 80306 |
|
1,432 |
1,326 |
$9K |
| 81001 |
|
5,347 |
4,915 |
$8K |
| 84703 |
|
2,122 |
1,980 |
$8K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
216 |
199 |
$8K |
| 83880 |
|
664 |
582 |
$7K |
| 85610 |
|
3,563 |
2,831 |
$7K |
| 87040 |
|
693 |
578 |
$7K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
280 |
272 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
280 |
272 |
$6K |
| 85730 |
|
2,054 |
1,819 |
$6K |
| 83605 |
|
1,146 |
970 |
$5K |
| 82728 |
|
1,048 |
953 |
$4K |
| 84702 |
|
921 |
672 |
$4K |
| 86140 |
|
1,763 |
1,543 |
$4K |
| 81025 |
|
1,975 |
1,826 |
$4K |
| 82150 |
|
1,219 |
1,089 |
$4K |
| 87400 |
|
596 |
537 |
$4K |
| 85379 |
|
977 |
878 |
$4K |
| 82550 |
|
1,231 |
1,046 |
$4K |
| 84481 |
|
736 |
698 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
432 |
420 |
$3K |
| 83550 |
|
730 |
689 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
205 |
183 |
$3K |
| 86901 |
|
1,352 |
1,252 |
$3K |
| 83540 |
|
934 |
874 |
$3K |
| 87641 |
|
126 |
110 |
$3K |
| 86850 |
|
926 |
851 |
$3K |
| 81003 |
|
2,314 |
2,097 |
$2K |
| 86780 |
|
281 |
264 |
$2K |
| 86900 |
|
1,353 |
1,254 |
$2K |
| 87088 |
|
364 |
310 |
$2K |
| 85652 |
|
1,529 |
1,412 |
$2K |
| 87070 |
|
579 |
519 |
$2K |
| 82553 |
|
426 |
385 |
$2K |
| 88304 |
|
66 |
63 |
$2K |
| 85027 |
|
573 |
450 |
$2K |
| 82570 |
|
556 |
503 |
$1K |
| 82043 |
|
638 |
604 |
$1K |
| 82746 |
|
218 |
208 |
$1K |
| 82962 |
|
834 |
285 |
$1K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
124 |
121 |
$1K |
| 83655 |
|
180 |
170 |
$1K |
| 80305 |
|
243 |
200 |
$1K |
| 84112 |
|
57 |
53 |
$1K |
| 87420 |
|
119 |
114 |
$932.05 |
| 82803 |
|
130 |
111 |
$870.68 |
| 87340 |
|
126 |
115 |
$833.94 |
| 82805 |
|
146 |
88 |
$809.69 |
| 86756 |
|
90 |
78 |
$717.04 |
| 86803 |
|
83 |
76 |
$694.72 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
157 |
156 |
$688.39 |
| 82950 |
|
276 |
269 |
$643.08 |
| 87077 |
|
97 |
73 |
$550.52 |
| 83615 |
|
183 |
147 |
$526.88 |
| 87210 |
|
205 |
200 |
$490.61 |
| 87205 |
|
271 |
213 |
$486.34 |
| 84100 |
|
337 |
149 |
$440.26 |
| 82375 |
|
172 |
100 |
$380.74 |
| 84550 |
|
189 |
167 |
$380.62 |
| 80076 |
|
147 |
123 |
$330.32 |
| 86038 |
|
42 |
41 |
$327.68 |
| 86787 |
|
33 |
29 |
$261.50 |
| 80202 |
|
39 |
16 |
$252.14 |
| 83050 |
|
150 |
88 |
$216.98 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
14 |
13 |
$175.00 |
| 84157 |
|
115 |
106 |
$146.40 |
| 86225 |
|
24 |
24 |
$137.48 |
| 86920 |
|
35 |
29 |
$136.30 |
| 84466 |
|
34 |
31 |
$135.13 |
| 80069 |
|
40 |
26 |
$130.58 |
| 86762 |
|
30 |
30 |
$123.00 |
| 85018 |
|
120 |
100 |
$121.44 |
| 85014 |
|
111 |
93 |
$114.30 |
| 83001 |
|
12 |
12 |
$109.08 |
| 82105 |
|
12 |
12 |
$98.31 |
| 82247 |
|
26 |
13 |
$42.22 |
| 86592 |
|
19 |
18 |
$37.85 |
| 82565 |
|
23 |
16 |
$37.35 |
| 84156 |
|
14 |
12 |
$16.10 |
| 84145 |
|
46 |
43 |
$0.00 |
| 85007 |
|
12 |
12 |
$0.00 |